KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bausch Health Companies (BHC) Cost of Revenue: 2009-2024

Historic Cost of Revenue for Bausch Health Companies (BHC) over the last 16 years, with Dec 2024 value amounting to $2.7 billion.

  • Bausch Health Companies' Cost of Revenue rose 7.77% to $735.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 billion, marking a year-over-year increase of 6.04%. This contributed to the annual value of $2.7 billion for FY2024, which is 8.34% up from last year.
  • Latest data reveals that Bausch Health Companies reported Cost of Revenue of $2.7 billion as of FY2024, which was up 8.34% from $2.5 billion recorded in FY2023.
  • Over the past 5 years, Bausch Health Companies' Cost of Revenue peaked at $2.7 billion during FY2024, and registered a low of $2.2 billion during FY2020.
  • In the last 3 years, Bausch Health Companies' Cost of Revenue had a median value of $2.5 billion in 2023 and averaged $2.5 billion.
  • Per our database at Business Quant, Bausch Health Companies' Cost of Revenue decreased by 4.14% in 2020 and then rose by 8.77% in 2023.
  • Over the past 5 years, Bausch Health Companies' Cost of Revenue (Yearly) stood at $2.2 billion in 2020, then grew by 6.72% to $2.4 billion in 2021, then declined by 1.45% to $2.3 billion in 2022, then rose by 8.77% to $2.5 billion in 2023, then grew by 8.34% to $2.7 billion in 2024.